Skip to main content

US Findings in Gynecologic Cancer

  • Chapter
  • First Online:
  • 1655 Accesses

Abstract

>Sonography (Ultrasound-US) is considered as a first-line imaging modality for the evaluation of female pelvis. It has a significant role in the management of patients with vaginal bleeding, especially in postmenopausal population and for detection of endometrial cancer. Also, it is useful in identifying and characterizing ovarian lesions in up to 75% of the cases. However, sonography exhibits considerable limitations in evaluating uterine cervix or localizing quite large pelvic masses; furthermore, its role in staging and follow up of gynecologic malignancies is still restricted. The development of more sophisticated techniques, like contrast-enhanced or three dimensional US, may improve diagnostic efficacy in the future.The aim of this chapter is to describe common sonographic features of uterine and ovarian malignancies and to review the diagnostic efficacy of sonography in such cases.

Ultrasonography (US) is considered as the initial imaging method for the evaluation of the female pelvis. It is a noninvasive, easily repeatable, cheap, and widely available imaging modality, which provides a quick overview of the female reproductive system. Since it lacks ionization, it is a safe method for the evaluation of young females and pregnant patients (Fielding et al. Gynecologic imaging. Expert radiology series. Elsevier Saunders, Philadelphia, PA, 2011; Fischerova, Ultrasound Obstet Gynecol 38:246–266, 2011).

Bimanual clinical examination has low sensitivity in recognizing uterine and ovarian tumors (Padilla et al., Obstet Gynecol 96:593–598, 2000). On the contrary, US can easily detect and characterize pelvic masses of uterine or adnexal origin, predicting also their benign or malignant nature.

US may be susceptible to pitfalls since it is dependent on the operator’s experience, equipment, and patient’s body mass index. During the last decades, there was a significant improvement in technical quality parameters; therefore, US can be used as a reliable tool for the depiction and classification of most gynecological tumors, for follow-up examination, and even for the detection of recurrence in oncologic patients, especially when carried out by a sonographer dedicated in gynecologic oncology (Fischerova, Ultrasound Obstet Gynecol 38:246–266, 2011).

The aim of this chapter is to describe typical sonographic features of common uterine and ovarian malignancies in pre- and postmenopausal population and to review the diagnostic efficacy of sonography in such cases.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Fielding J, Brown D, Thurmond A (2011) Gynecologic imaging. Expert radiology series. Elsevier Saunders, Philadelphia, PA

    Google Scholar 

  2. Fischerova D (2011) Ultrasound scanning of the pelvis and abdomen for staging of gynecological tumors: a review. Ultrasound Obstet Gynecol 38:246–266

    Article  CAS  Google Scholar 

  3. Derchi L, Serafini G, Gandolfo N et al (2001) Ultrasound in gynecology. Eur Radiol 11:2137–2155

    Article  CAS  Google Scholar 

  4. Timmermans A, Opmeer BC, Khan KS, Bachmann LM, Epstein E, Clark TJ et al (2010) Endometrial thickness measurement for detecting endometria cancer in women with postmenopausal bleeding: a systematic review and meta-analysis. Obstet Gynecol 116(1):160–167

    Article  Google Scholar 

  5. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice (2006) ACOG committee opinion no. 336: tamoxifen and uterine cancer. Obstet Gynecol 107(6):1475–1478

    Article  Google Scholar 

  6. Liu ZZ, Jiang YX, Qing D et al (2011) Imaging in endometrial carcinoma using contrast-enhanced sonography. J Ultrasound Med 30(11):1519–1527

    Article  Google Scholar 

  7. Rumack C, Wilson S, Chaborneau JW (1998) Diagnostic ultrasound, vol 1, 2nd edn. Mosby Inc., St. Louis, MO

    Google Scholar 

  8. Loubeyre P, Navarria I, Undurraga M et al (2012) Is imaging relevant for treatment choice in early stage cervical uterine cancer? Surg Oncol 21:e1–e6

    Article  Google Scholar 

  9. McCluggage WG, Fisher C, & Hirschowitz LDL, On behalf of the Working Group for Cancer Services of The Royal College of Pathologists (2014) Dataset for histological reporting of uterine sarcomas. http://www.rcpath.org/Resources/RCPath/Migrated%20Resources/Documents/G/G106_UterineSarcomaDataset_Dec14.pdf

  10. Hricak H (2007) Diagnostic imaging. Gynecology, 1st edn. Amirsys Inc., Salt Lake City, UT

    Google Scholar 

  11. Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian Masses (2009) JOGC JULY JUILLET no. 230

    Google Scholar 

  12. Timmerman D, Testa AC, Bourne T et al (2008) Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound Obstetr Gynecol 31(6):681–690

    Article  CAS  Google Scholar 

  13. Togashi K (2003) Ovarian cancer: the clinical role of US, CT, and MRI. Eur Radiol 13:L87–L104

    Article  Google Scholar 

  14. Fleischer A, Lyshchik A, Hirari M et al (2012) Early detection of ovarian cancer and contrast-enhanced transvaginal sonography: recent advances and potential improvements. J Oncol 302858:11

    Google Scholar 

  15. Marret H, Sauget S, Giraudeau B et al (2004) Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses. JUM 23(12):1629–1639

    Google Scholar 

  16. Buys SS, Partridge E, Black A et al (2011) Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial. JAMA 305(22):2295–2303

    Article  CAS  Google Scholar 

  17. Van Nagel JR, Pavlik EJ (2012) Ovarian cancer screening. Clin Obstet Gynecol 55(1):43–51

    Article  Google Scholar 

  18. Tempany CM, Zou KH, Silverman SG et al (2000) Staging of advanced ovarian cancer: comparison of imaging modalities-report from the radiological diagnostic oncology group. Radiology 215:761–767

    Article  CAS  Google Scholar 

  19. Kurtz AB, Tsimikas JV, Tempany CM et al (1999) Diagnosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis – report from the radiological diagnostic oncology group. Radiology 212:19–27

    Article  CAS  Google Scholar 

  20. Fehm T, Heller F, Kramer S et al (2005) Evaluation of CA125, physical and radiological findings in follow up of ovarian cancer patients. Anticancer Res 25:1551–1554

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bourgioti, C.I., Antoniou, A. (2018). US Findings in Gynecologic Cancer. In: Gouliamos, A., Andreou, J., Kosmidis, P. (eds) Imaging in Clinical Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-68873-2_41

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-68873-2_41

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-68872-5

  • Online ISBN: 978-3-319-68873-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics